首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Multiple sclerosis journal-experimental translational and clinical

缩写:

ISSN:N/A

e-ISSN:2055-2173

IF/分区:2.0/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引623
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sarah M Planchon,Karen T Lingas,Jane Reese Koç et al. Sarah M Planchon et al.
Background: Multiple sclerosis is an inflammatory, neurodegenerative disease of the central nervous system for which therapeutic mesenchymal stem cell transplantation is under study. Published experience of culture-expand...
Eva Havrdová,Douglas L Arnold,Amit Bar-Or et al. Eva Havrdová et al.
Background: No evidence of disease activity (NEDA; defined as no 12-week confirmed disability progression, no protocol-defined relapses, no new/enlarging T2 lesions and no T1 gadolinium-enhancing lesions) using a fixed-st...
François Jacques,Adrian Schembri,Avi Nativ et al. François Jacques et al.
Background: Both prolonged-release fampridine (PRF) and enabling active motor training (EAMT) are beneficial in multiple sclerosis (MS) patients. Their combined effect is, however, understudied. ...
Yuki Matsumoto,Mario Tsuchiya,Shakespear Norshalena et al. Yuki Matsumoto et al.
A 26-year-old, 17-week pregnant woman developed aquaporin-4-IgG-positive severe longitudinally extensive transverse myelitis during the course of disseminated herpes zoster and became quadriparetic. She was unresponsive to high-dose intrave...
Brian M Sandroff,Glenn R Wylie,Brad P Sutton et al. Brian M Sandroff et al.
Exercise training has been identified as a highly promising approach for managing the cognitive consequences of multiple sclerosis (MS). This study represents a secondary analysis of resting-state functional connectivity (RSFC) magnetic res...
Ryohei Ohtani,Masahiro Mori,Tomohiko Uchida et al. Ryohei Ohtani et al.
Background: Lymphopenia is a well-known adverse event of fingolimod, a disease-modifying drug for multiple sclerosis (MS). Objectives: ...
M Mäurer,K Schuh,S Seibert et al. M Mäurer et al.
Background: Fatigue is a major symptom of multiple sclerosis (MS) in patients, and it has been shown to improve with physical exercise. Although fingolimod might lessen fatigue, it is unclear how patients treated with fin...
Victoria Mj Smith,Jonathan S Varsanik,Rachel A Walker et al. Victoria Mj Smith et al.
Background: Gait disturbance is a major contributor to clinical disability in multiple sclerosis (MS). A sensor was developed to assess walking speed at home for people with MS using infrared technology in real-time witho...
J E Sasaki,R W Motl,G Cutter et al. J E Sasaki et al.
Background: Limited data exist on the prevalence and distribution of sedentary behavior (SB) in multiple sclerosis (MS). Objective: The...
Carlos Navas,Carlos A Torres-Duque,Joe Munoz-Ceron et al. Carlos Navas et al.
Background: Multiple sclerosis is an inflammatory and neurodegenerative demyelinating disease. Current treatment of multiple sclerosis focuses on the use of immunomodulatory, immunosuppressant, and selective immunosuppres...